US › Healthcare

China SXT Pharmaceuticals Inc (SXTC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.07-5.52%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$1.2M

Revenue YoY

+163.0%

Net profit

$163,718

EPS

$-0.05

EPS estimate

$0.00

Net margin

13.7%

Key statistics

Market cap

$673,237

Forward P/E

0.0

P/B

0.11

Book value

$2,480.58

EPS (TTM)

$-693.50

52-week high

$24,000.00

52-week low

$0.06

50-day MA

$2.61

200-day MA

$871.18

Beta

1.86

Shareholding

Insiders

0.53%

Largest institutional holders

Fund	Stake
Royal Bank of Canada	0.00%
Caitong International Asset Management Co., Limited.	0.00%
UBS Group AG	0.00%
Amvescap Plc.	0.00%
Sabby Management LLC	0.00%
Geode Capital Management, LLC	0.00%
Tower Research Capital LLC	0.00%
Citadel Advisors Llc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for China SXT Pharmaceuticals Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.